Detalhe da pesquisa
1.
Inactivated genotype 1a, 2a and 3a HCV vaccine candidates induced broadly neutralising antibodies in mice.
Gut
; 72(3): 560-572, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35918103
2.
Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice.
J Hepatol
; 76(5): 1051-1061, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34990750
3.
Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants.
Hepatology
; 70(3): 771-787, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30964552
4.
An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals.
iScience
; 26(2): 105949, 2023 Feb 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36644321
5.
High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor.
Vaccines (Basel)
; 10(2)2022 Feb 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35214707
6.
SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor.
Vaccines (Basel)
; 9(7)2021 Jun 29.
Artigo
Inglês
| MEDLINE | ID: mdl-34209694
7.
Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency.
Vaccines (Basel)
; 8(2)2020 Jun 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32532076